The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Ampicillin and Sulbactam
ampicillin and sulbactam · AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM .5 g/1 · Injection, Powder, For Solution · Intramuscular; Intravenous · Avenacy, LLC
NDC 83634-0109-20 · 10 VIAL, SINGLE-DOSE in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$35.00
Reported to Texas DSHS · 2026 annual filing · Avenacy Inc
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA065222
- TE code
- AP
- Approval date
- Nov 29, 2005
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of ampicillin and sulbactam (Injection, Powder, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Avenacy, LLC | AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM .5 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Avenacy, LLC | AMPICILLIN SODIUM 10 g/1; SULBACTAM SODIUM 5 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Avenacy, LLC | AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | AMPICILLIN SODIUM 100 mg/mL; SULBACTAM SODIUM 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | AMPICILLIN SODIUM 2 g/3g; SULBACTAM SODIUM 1 g/3g | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | AMPICILLIN SODIUM 1 g/1.5g; SULBACTAM SODIUM .5 g/1.5g | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | AMPICILLIN SODIUM 100 mg/mL; SULBACTAM SODIUM 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM .5 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM .5 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | AMPICILLIN SODIUM 10 g/1; SULBACTAM SODIUM 5 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | SULBACTAM SODIUM 1 g/1; AMPICILLIN SODIUM 2 g/1 | Aug 26, 2026 | Aug 28, 2026 |
| WG Critical Care, LLC | SULBACTAM SODIUM 2 g/1; AMPICILLIN SODIUM 1 g/1 | Jul 22, 2026 | Aug 22, 2026 |
| WG Critical Care, LLC | AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g/1 | Jul 15, 2026 | Jul 19, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Ampicillin and Sulbactam — NDC 83634-0109-20," retrieved September 3, 2026, https://drugdashboards.com/drug/83634010920.
Free to cite with attribution — see how the data is put together.